Nick Wood, RPH - Pharmacist in Centreville, AL

Nick Wood, RPH is a Pharmacist based in Centreville, Alabama. Nick Wood is licensed to practice in Alabama (license number 12086) and his current practice location is 155 Birmingham Rd Ste 114, Centreville, Alabama. He can be reached at his office (for appointments etc.) via phone at (205) 926-4654.

NPI number for Nick Wood is 1417551060 and his current mailing address is 155 Birmingham Rd Ste 114, Centreville, Alabama. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1417551060.

Contact Information

Nick Wood, RPH
155 Birmingham Rd Ste 114,
Centreville, AL 35042-2949
(205) 926-4654
(205) 926-5205

Healthcare Provider's Profile

Full NameNick Wood
GenderMale
SpecialityPharmacist
Location155 Birmingham Rd Ste 114, Centreville, Alabama
Accepts Medicare AssignmentsDoes not participate in Medicare Program. He may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1417551060
  • Provider Enumeration Date: 11/24/2020
  • Last Update Date: 11/24/2020

Medical Identifiers

Medical identifiers for Nick Wood such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1417551060NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
183500000XPharmacist 12086 (Alabama)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Nick Wood is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Nick Wood, RPH
155 Birmingham Rd Ste 114,
Centreville, AL 35042-2949

Ph: (205) 926-4654
Nick Wood, RPH
155 Birmingham Rd Ste 114,
Centreville, AL 35042-2949

Ph: (205) 926-4654

News Archive

Research: Children with inherited anti-inflammatory defect may have predisposition to lymphoma

New research shows that children with an inherited genetic defect in a critical anti-inflammatory pathway have a genetic predisposition to lymphoma. Results of the study, published online today in Blood, the Journal of the American Society of Hematology (ASH), reveal an important association between the genetic defect, which causes chronic intestinal inflammation and early onset inflammatory bowel disease, and its role in cancer development in infants and children.

Africa meets certification criteria for wild polio eradication

The independent Africa Regional Certification Commission for Polio Eradication officially declared on Tuesday that the World Health Organization African Region is free of wild poliovirus.

Weekend reading: What your doctor should tell you, new stages of grief

Dr. Jim Dougher climbs into his white SUV, plugs the address of his next patient into the GPS, and he's off. The SUV is well stocked: He has a large Tupperware bin in the back full of bandages and wound cleaning supplies; he has a variation on the old-time doctor's bag with a stethoscope and blood-pressure cuff; and he has a dedicated cellular wifi hotspot and a laptop that can communicate with HealthCare Partner's electronic medical record.

Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy

An interdisciplinary team of researchers at Brigham and Women's Hospital and the Harvard-Massachusetts Institute of Technology (MIT) Division of Health Sciences and Technology has demonstrated a better way to deliver cancer drugs directly to tumors.

Biovail files abbreviated new drug application for Fenofibrate tablets

Biovail Corporation today announced that the United States Food and Drug Administration (FDA) has accepted the Company's abbreviated new drug application (ANDA) for a generic formulation of 145mg and 48mg strengths of fenofibrate tablets (sold under the brand name Tricor by Abbott Laboratories).

Read more News

› Verified 7 days ago


Pharmacist in Centreville, AL

Sumer Hudson Holdsambeck, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1130 Walnut St, Centreville, AL 35042
Phone: 205-926-4821    Fax: 205-926-7662
Mandi Linn Woodruff, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 405 Belcher St, Centreville, AL 35042
Phone: 205-206-5733    
Dr. Seth Young, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1130 Walnut St, Centreville, AL 35042
Phone: 205-926-4821    
Mrs. Melody Dawn Randolph, PHARM D
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1130 Walnut Street, Centreville, AL 35042
Phone: 205-926-4821    Fax: 205-926-7662
Ms. Tresa Ray House, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 208 Pierson Ave, Centreville, AL 35042
Phone: 205-926-3277    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.